Home management of pain crises of sickle cell disease in Togo;Traitement a domicile de la crise vaso-occlusive par les drepanocytaires au Togo

Archives de Pediatrie

Volumn 6, Issue 9, 1999, Pages 958-961

  Gbadoe A D ^a,b   Atakouma, D Y ^a   Akoli, A ^a   Assimadi, J K ^a  

^a UNIVERSITÉ DE LOMÉ   (Togo)

^b NONE   (Togo)

Author keywords

Acetaminophen; Anemia, sickle cell; Pain; Pain measurement; Salicylates

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PENTOXIFYLLINE; SALICYLIC ACID; VASODILATOR AGENT; ANALGESIC AGENT;

ARTICLE; CHILD; FLUID THERAPY; HEALTH EDUCATION; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; PAIN; QUALITY OF LIFE; RURAL POPULATION; SCORING SYSTEM; SICKLE CELL ANEMIA; TOGO; URBAN POPULATION; ADULT; DEVELOPING COUNTRY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG UTILIZATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE;

ADULT; ANALGESICS; ANEMIA, SICKLE CELL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTERIAL OCCLUSIVE DISEASES; CHILD; DEVELOPING COUNTRIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; FLUID THERAPY; HOME NURSING; HUMANS; PAIN; TOGO; VASODILATOR AGENTS;

EID: 0033178183     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(99)80588-0     Document Type: Article

References (13)

1. Payne R. Pain management in sickle cell disease. Rationale and techniques. Ann NY Acad Sci 1988; 565 : 189-206.
2. Shapiro BS, Dinges DF, Orne EC, Bauer N, Reilly LB, Whitehouse WG, et al. Home management of sickle cell-related pain in children and adolescents: Natural history and impact on school attendance. Pain 1995; 61 : 139-44.
3. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crisis in sickle cell anemia. N Engl J Med 1995; 332 : 1317-22.
4. Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, et al. Hydroxyurea, and sickle cell anemia: Clinical utility of a hemoglobin myelosuppressive "switching" agent. Medicine 1996; 75 : 300-26.
5. Rogers ZR. Hydroxyurea therapy for diverse pediatrie populations with sickle cell disease. Semin Hematol 1997; 34 : 42-7.
6. Shapiro BS, Cohen DE, Howe CJ. Patient controlled analgesia for sickle cell-related pain. J Pain Symptom Manage 1993; 8 : 22-8.
7. Brozovic M, Davies SC, Brownell AI. Acute admissions of patients with sickle cell disease who live in Britain. Br Med J Clin Res 1987; 294 : 1206-8.
8. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Ross WF, Vichinsky E, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991; 325 : 11-6.
9. Ballas SK. Treatment of pain in adults with sickle cell disease. Am J Hematol 1990; 34 : 49-54.
10. Shapiro BS. Management of painful episodes in sickle cell disease. In: Schechter NL, Berde CB, Vaster Y, eds. Pain in Infant, Children and Adolescents. Baltimore: Williams and Wilkins; 1993. p. 385-406.
11. Conner-Warren RL. Pain intensity and home pain management of children with sickle cell disease. Issues Compr Pediatr Nurs 1996; 19 : 183-95.
12. Gbadoé AD, Foovi K, Atakouma DY, Dogba MA, Nyadanu K, Késsié K, et al. Traitement de la crise vaso-occlusive drépanocytaire: Enquête auprès du personnel soignant de la commune de lomé (Togo). Ann Pediatr 1999; 6 : 193-8.
13. Ballas SK. Management of sickle pain. Curr Opin Hematol 1997; 4 : 104-11.